Pharmacology, Toxicology and Pharmaceutical Science
Calcitonin Gene Related Peptide
100%
Migraine
89%
Receptor
66%
Capsaicin
52%
Cinnamaldehyde
52%
Transient Receptor Potential Channel
52%
Vanilloid Receptor 1
43%
Transient Receptor Potential Channel A1
34%
Transient Receptor Potential Channel M3
34%
Headache
34%
SARS Coronavirus
34%
Oxytocin
34%
Prolactin
34%
Vascular Disease
34%
Ankyrin
26%
Olcegepant
26%
Dextro Aspartic Acid
26%
Calcitonin Gene Related Peptide Receptor
23%
Apamin
20%
Clinical Trial
17%
Vanilloids
17%
Pregnenolone Sulfate
17%
Prostaglandin Synthase
17%
Indometacin
17%
Potassium Channel
17%
Capsazepine
17%
Nitric Oxide Synthase
17%
High-Content Screening
17%
Pathophysiology
14%
Messenger RNA
14%
Neuropeptide
13%
Monoclonal Antibody
10%
Diseases
9%
N Methyl Dextro Aspartic Acid Receptor
8%
N (4 Isopropylphenyl) 2 (1,2,3,6 Tetrahydro 1,3 Dimethyl 2,6 Dioxo 7h Purin 7 Yl)acetamide
8%
Prolactin Receptor
8%
Sex Hormone
8%
Western Blot
8%
Fluorescence Microscopy
8%
Forskolin
6%
Cardiovascular Risk
5%
Side Effect
5%
Phase IV
5%
Tolerability
5%
Adverse Event
5%
Coronavirinae
5%
Placebo
5%
Neuroscience
Migraine
72%
Prolactin
34%
Oxytocin
34%
SARS Coronavirus
34%
Headache
34%
Meta-Analysis
34%
Transient Receptor Potential Melastatin
34%
Sex Hormone
16%
Calcitonin
12%
Oxytocin Receptor
8%
Receptor
8%
Trigeminovascular System
7%
Coronavirus
5%
Placebo
5%
Coronavirinae
5%
Messenger RNA
5%
Pregnenolone Sulfate
5%
Medicine and Dentistry
Migraine
37%
Headache
34%
Meta-Analysis
34%
Systematic Review
34%
Severe Acute Respiratory Syndrome Coronavirus 2
34%
Vascular System
34%
Sex Difference
34%
Receptor Potential
34%
Calcitonin Gene Related Peptide
8%
Adverse Event
5%
COVID-19
5%
Placebo
5%
Messenger RNA
5%
Pregnenolone Sulfate
5%
Sex Hormone
5%
Prevalence
5%
Vascularity
5%
Meningeal Artery
5%
